Institution
Centre pour l'innovation en cancérologie de Lyon
FRfacility
Recent research
- Health & Medicine
An International Study of Pembrolizumab for Drug-Resistant Gestational Trophoblastic Neoplasia
BACKGROUND: Data to guide use of anti-PD1 immunotherapy with pembrolizumab for gestational trophoblastic neoplasia (GTN) that is chemotherapy-resistant or in adjuvant settings are limited. We conducted an international retrospective study of pembrolizumab in GTN, including patien...